4.6 Article

Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions

期刊

CANCERS
卷 13, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/cancers13112760

关键词

precursor lesions; intestinal type of gastric cancer; CpG methylation; Helicobacter pylori; cancer risk prediction

类别

资金

  1. Instituto de Salud Carlos III
  2. European Regional Development Funds (ERDF/FEDER) a way to build Europe [PI10/02267, PI10/01089, PI10/01203]
  3. COST [CM1406]
  4. People Program (MSCA-ITN-2014-ETN) of the European Union's Horizon 2020 Program under Chromatin 3D project [SEP-210147404]
  5. Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)

向作者/读者索取更多资源

Intestinal metaplasia is associated with an increased risk of gastric cancer, and finding molecular biomarkers can aid in guiding prevention programs. Helicobacter pylori infection influences DNA methylation, requiring early adoption of prevention strategies. Research suggests that intestinal metaplasia partially resembles the methylation patterns of intestinal gastric cancer.
Simple Summary Intestinal metaplasia confers an increased risk of progression to gastric cancer. However, some intestinal metaplasia patients do not develop cancer. The development of robust molecular biomarkers to stratify patients with advanced gastric precursor lesions at risk of cancer progression will contribute to guiding programs for prevention. Starting from a genome-wide methylation study, we have simplified the detection method regarding candidate-methylation tests to improve their applicability in the clinical environment. We identified CpG methylation at the ZNF793 and RPRM promoters as a common event in intestinal metaplasia and intestinal forms of gastric cancer. Furthermore, we also showed that Helicobacter pylori infection influences DNA methylation in early precursor lesions but not in intestinal metaplasia, suggesting that therapeutic strategies to prevent epigenome reprogramming toward a cancer signature need to be adopted early in the precursor cascade. To adopt prevention strategies in gastric cancer, it is imperative to develop robust biomarkers with acceptable costs and feasibility in clinical practice to stratified populations according to risk scores. With this aim, we applied an unbiased genome-wide CpG methylation approach to a discovery cohort composed of gastric cancer (n = 24), and non-malignant precursor lesions (n = 64). Then, candidate-methylation approaches were performed in a validation cohort of precursor lesions obtained from an observational longitudinal study (n = 264), with a 12-year follow-up to identify repression or progression cases. H. pylori stratification and histology were considered to determine their influence on the methylation dynamics. As a result, we ascertained that intestinal metaplasia partially recapitulates patterns of aberrant methylation of intestinal type of gastric cancer, independently of the H. pylori status. Two epigenetically regulated genes in cancer, RPRM and ZNF793, consistently showed increased methylation in intestinal metaplasia with respect to earlier precursor lesions. In summary, our result supports the need to investigate the practical utilities of the quantification of DNA methylation in candidate genes as a marker for disease progression. In addition, the H. pylori-dependent methylation in intestinal metaplasia suggests that pharmacological treatments aimed at H. pylori eradication in the late stages of precursor lesions do not prevent epigenome reprogramming toward a cancer signature.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据